accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. A certificate of attendance is available to medical professionals who do not collect CME credits.
The University of Miami Miller School of Medicine adheres to ACCME Standards regarding industry support of continuing medical education programs. Disclosure of faculty and commercial relationships, if any, will be made known at the beginning of each program.
Tools
>>Basal/Bolus Insulin Calculator
The DRI is offering, at no charge, a tool that helps health care professionals easily calculate a prescription for basal and bolus insulin replacement based on either a patient's weight or current daily insulin amount.
The prescription will provide practitioners with a basal insulin amount per day, as well as insulin doses needed to cover meals and high blood glucose levels.
This tool is adapted from an algorithm developed by Dr. Luigi Meneghini at the Diabetes Research Institute. To access the calculator, click here.
>>Practical Tools for Glycemic Control in Type 2 Diabetes: Introducing Basal/Bolus Insulin Therapy
The goals of this monograph are:
- Discuss the rationale for improving metabolic control in type 2 diabetes
- Understand why and how to advance diabetes therapy
- Initiate insulin therapy in type 2 diabetes
- Recognize the physiology of glucose homeostasis and physiologic insulin secretion
- Differentiate basal insulin replacement from bolus therapy
- Translate basal/bolus concepts into an insulin prescription for intensive therapy
- Identify and address patient and physician barriers to intensive insulin therapy
Presentations
>>Achieving and Maintaining Normoglycemia in Type 2 Diabetes
Review of pathophysiology of Type 2 Diabetes and identifying the glycemic burden. Targeting therapies to maximize blood glucose control. Algorithms for starting and adjusting therapies to optimize glycemic management.
>>Basal/Bolus Therapy in Type 2 Diabetes
Understanding when to consider rapid acting insulin treatment. Discuss how to advance from conventional insulin therapy to a practical basal/bolus approach in the insulin-deficient patient with Type 2 diabetes.
>>Diabetes Mellitus Type 2: Newer Agents
>>Hypoglycemia in Diabetes and Beyond
This presentation reviews the physiology of counter-regulatory hormone response to hypoglycemia and explores the defects in response seen in patients with diabetes. Evaluation, diagnosis and treatment of counter-regulatory defects, hypoglycemia unawareness and severe hypoglycemia are discussed. In addition, this presentation addresses the evaluation of the patient without diabetes that presents for evaluation of hypoglycemia. The appropriate work-up, diagnostic algorithm and treatment strategies are discussed.
>>In Hospital Management of Diabetes Mellitus
Discussion of Hyperglycemia management in a hospital setting.
>>Initiating and Advancing Insulin Therapy in Type 2 Diabetes
Rationale for early insulin treatment in patients failing to achieve glycemic goals on oral therapy. Starting with basal insulin replacement.
>>Microvascular Disease: Screening, Prevention and Management of Chronic Complications
A physiologic review of the relationship between glycemic control and the development of microvascular complications. Early screening, detection and aggressive management of microvascular disease.
>>Poorly Controlled Type 2 Diabetes Mellitus: Insulin vs. Additional Oral Agents
This presentation reviews effective strategies for advancing therapy in type 2 diabetes. Learn how to implement effective insulin options and replacement strategies, specifically Basal insulin analogs versus NPH and Basal dose adjustments. Understand the role and expected outcomes of incretin therapy (exenatide) and discover how to intensify insulin therapy beyond basal insulin replacement.
>>Standards of Medical Care in Diabetes
Discussion of treatment guidelines for the prevention of microvascular and macrovascular disease and hallmark clinical trials supporting these recommendations.
>>Tackling Head on Macrovascular Disease in Type 2 Diabetes
A physiologic review of dyslipidemia, metabolic syndrome and cardiovascular disease therapeutic interventions to reduce the progression diabetes-related co-morbidities.
>>Treatment of Painful Diabetic Neuropathy
This presentation reviews the pathophysiology of peripheral nerve injury in diabetes and discus
ses tools for evaluating and classifying diabetic neuropathy on history and physical examination. An algorithmic approach to the management of painful diabetic neuropathy incorporates both approved and over-the-counter treatments that have shown to be effective in the management of neuropathic pain and compares their effectiveness and safety.
Industry Training
We offer customized training programs created with specific goals to educate industry professionals. Please call our Professional Education department at 305-243-1062 for more information.